Finance

Beta
Lists
TOI:NASDAQ
Oncology Institute Inc
$5.60
+3.90%
(+0.21) 1D
$5.70
+1.79% (+0.100)
Pre-market
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TOI...
Open
$5.48
High
$5.82
Low
$5.41
Mkt. cap
559.90M
Avg. vol.
1.88M
Volume
1.10K
52-wk high
$5.82
52-wk low
$2.02
EPS
-$0.38
Beta
0.35
Shares outstanding
99.98M
No. of employees
641
Open
$5.48
High
$5.82
Low
$5.41
Mkt. cap
559.90M
Avg. vol.
1.88M
Volume
1.10K
52-wk high
$5.82
52-wk low
$2.02
EPS
-$0.38
Beta
0.35
Shares outstanding
99.98M
No. of employees
641
News stories
From sources across the web
About Oncology Institute Inc
CEO-
Employees641
Founded2007
HeadquartersCerritos, California, United States
SectorHealth care provider
Websitetheoncologyinstitute.com
Analyst ratings
Based on 3 analysts giving stock ratings to TOI in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TOI in the last 3 months.
Highest
Current $5.60
$8.00 (+42.86%)
Average
$7.67 (+36.96%)
Lowest
$7.00 (+25.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Shea
Needham
Buy
Reiterated
$7.00
+25%
06/17/2026
David Larsen
BTIG
Buy
Maintained
$8.00
+42.9%
06/08/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$8.00
+42.9%
05/08/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
$8.00
+42.9%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
119.80M
136.56M
141.96M
147.44M
Cost of goods sold
102.30M
117.64M
119.19M
124.13M
Cost of revenue
102.30M
117.64M
119.19M
124.13M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.91M
25.25M
28.04M
28.21M
Operating expense
28.71M
26.97M
29.67M
29.83M
Total operating expenses
131.01M
144.62M
148.86M
153.95M
Operating income
-11.21M
-8.05M
-6.91M
-6.51M
Other non operating income
-4.06M
-6.53M
1.31M
5.96M
EBT including unusual items
-17.14M
-16.50M
-7.51M
-2.49M
EBT excluding unusual items
-17.14M
-16.50M
-7.51M
-2.49M
Income tax expense
-131.00K
-
-
-
Effective tax rate
0.76%
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.01M
-16.50M
-7.51M
-2.49M
Net profit margin
-14.20%
-12.09%
-5.29%
-1.69%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.87M
-1.92M
-1.92M
-1.93M
Net interest expenses
-1.87M
-1.92M
-1.92M
-1.93M
Depreciation and amortization charges
1.80M
1.72M
1.63M
1.62M
EBITDA
-9.41M
-6.33M
-5.28M
-4.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer